List of Excipients in API IBANDRONATE SODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing IBANDRONATE SODIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genentech Inc | BONIVA | ibandronate sodium | 0004-0186 | CELLULOSE, MICROCRYSTALLINE | |
| Genentech Inc | BONIVA | ibandronate sodium | 0004-0186 | CROSPOVIDONE | |
| Genentech Inc | BONIVA | ibandronate sodium | 0004-0186 | HYPROMELLOSE | |
| Genentech Inc | BONIVA | ibandronate sodium | 0004-0186 | LACTOSE MONOHYDRATE | |
| Genentech Inc | BONIVA | ibandronate sodium | 0004-0186 | POLYETHYLENE GLYCOL 6000 | |
| Genentech Inc | BONIVA | ibandronate sodium | 0004-0186 | POVIDONE K25 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing IBANDRONATE SODIUM
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Accord Healthcare Inc | ibandronate sodium | 16729-274 | ACETIC ACID |
| Accord Healthcare Inc | ibandronate sodium | 16729-274 | SODIUM ACETATE |
| Accord Healthcare Inc | ibandronate sodium | 16729-274 | SODIUM CHLORIDE |
| Accord Healthcare Inc | ibandronate sodium | 16729-274 | WATER |
| Sagent Pharmaceuticals | ibandronate sodium | 25021-827 | ACETIC ACID |
| Sagent Pharmaceuticals | ibandronate sodium | 25021-827 | SODIUM ACETATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for IBANDRONATE SODIUM
Excipient focus: ACETIC ACID
IBANDRONATE SODIUM drug variants containing ACETIC ACID
IBANDRONATE SODIUM drug variants not containing ACETIC ACID
Excipient focus: AMMONIA
IBANDRONATE SODIUM drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing AMMONIA
Excipient focus: CELLULOSE, MICROCRYSTALLINE
IBANDRONATE SODIUM drug variants containing CELLULOSE, MICROCRYSTALLINE
IBANDRONATE SODIUM drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
IBANDRONATE SODIUM drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
IBANDRONATE SODIUM drug variants containing CROSPOVIDONE
IBANDRONATE SODIUM drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE YELLOW
IBANDRONATE SODIUM drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | ibandronate sodium | 47781-103 |
| Bionpharma Inc | ibandronate sodium | 69452-378 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
IBANDRONATE SODIUM drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
IBANDRONATE SODIUM drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Alvogen Inc | ibandronate sodium | 47781-103 |
| Golden State Medical Supply Inc | ibandronate sodium | 60429-643 |
| Apotex Corp | ibandronate sodium | 60505-2795 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
IBANDRONATE SODIUM drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ibandronate sodium | 65862-237 |
| Bionpharma Inc | ibandronate sodium | 69452-378 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
IBANDRONATE SODIUM drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | ibandronate sodium | 33342-150 |
| Physicians Total Care Inc | ibandronate sodium | 54868-5322 |
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Genentech Inc | ibandronate sodium | 0004-0191 |
| Accord Healthcare Inc | ibandronate sodium | 16729-274 |
| Sagent Pharmaceuticals | ibandronate sodium | 25021-827 |
| Alvogen Inc | ibandronate sodium | 47781-103 |
| TAGI Pharma Inc | ibandronate sodium | 51224-008 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
IBANDRONATE SODIUM drug variants containing LACTOSE MONOHYDRATE
IBANDRONATE SODIUM drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
IBANDRONATE SODIUM drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | ibandronate sodium | 33342-150 |
| Golden State Medical Supply Inc | ibandronate sodium | 60429-643 |
| Apotex Corp | ibandronate sodium | 60505-2795 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Genentech Inc | ibandronate sodium | 0004-0191 |
| Accord Healthcare Inc | ibandronate sodium | 16729-274 |
| Sagent Pharmaceuticals | ibandronate sodium | 25021-827 |
| Alvogen Inc | ibandronate sodium | 47781-103 |
| TAGI Pharma Inc | ibandronate sodium | 51224-008 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
IBANDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | ibandronate sodium | 33342-150 |
| Alvogen Inc | ibandronate sodium | 47781-103 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
IBANDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
IBANDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Physicians Total Care Inc | ibandronate sodium | 54868-5322 |
| Bionpharma Inc | ibandronate sodium | 69452-378 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
IBANDRONATE SODIUM drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | ibandronate sodium | 60429-643 |
| Apotex Corp | ibandronate sodium | 60505-2795 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POVIDONE
IBANDRONATE SODIUM drug variants containing POVIDONE
IBANDRONATE SODIUM drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
IBANDRONATE SODIUM drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing POVIDONE K25
Excipient focus: PROPYLENE GLYCOL
IBANDRONATE SODIUM drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
IBANDRONATE SODIUM drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
IBANDRONATE SODIUM drug variants containing SILICON DIOXIDE
IBANDRONATE SODIUM drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ACETATE
IBANDRONATE SODIUM drug variants containing SODIUM ACETATE
IBANDRONATE SODIUM drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM CHLORIDE
IBANDRONATE SODIUM drug variants containing SODIUM CHLORIDE
IBANDRONATE SODIUM drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM STEARYL FUMARATE
IBANDRONATE SODIUM drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | ibandronate sodium | 47781-103 |
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| Aurobindo Pharma Limited | ibandronate sodium | 65862-237 |
| Bionpharma Inc | ibandronate sodium | 69452-378 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STEARIC ACID
IBANDRONATE SODIUM drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Physicians Total Care Inc | ibandronate sodium | 54868-5322 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing STEARIC ACID
Excipient focus: TALC
IBANDRONATE SODIUM drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Macleods Pharmaceuticals Limited | ibandronate sodium | 33342-150 |
| Physicians Total Care Inc | ibandronate sodium | 54868-5322 |
| Aurobindo Pharma Limited | ibandronate sodium | 65862-237 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
IBANDRONATE SODIUM drug variants containing TITANIUM DIOXIDE
IBANDRONATE SODIUM drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
IBANDRONATE SODIUM drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | ibandronate sodium | 65862-237 |
| >Company | >Ingredient | >NDC |
IBANDRONATE SODIUM drug variants not containing TRIACETIN
Excipient focus: WATER
IBANDRONATE SODIUM drug variants containing WATER
IBANDRONATE SODIUM drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Genentech Inc | ibandronate sodium | 0004-0186 |
| Macleods Pharmaceuticals Limited | ibandronate sodium | 33342-150 |
| Dr Reddy's Laboratories Limited | ibandronate sodium | 55111-575 |
| Aurobindo Pharma Limited | ibandronate sodium | 65862-237 |
| Bionpharma Inc | ibandronate sodium | 69452-378 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
